Research, CPD and Learning: 2022 in review Celebrating the highlights from 2022 and a look ahead to 2023.…
Developments in the management of anaemia and other complications in adults with chronic kidney disease An overview of updates to guidance on the management of chronic kidney disease and advancements in treatment for anaemia in patients with chronic kidney disease.…
Diabetes drug to treat chronic kidney disease in adults has licence extension granted The Medicines and Healthcare products Regulatory Agency has granted a licence extension for dapagliflozin, after promising trial results.…
How my part-time medicines safety PhD changed prescribing practice for older people Pharmacist Su Wood’s work on estimating reduced kidney function led to a major change in national recommendations for prescribing in older people.…
At last, a new treatment option for diabetes-related chronic kidney disease Guideline-changing trial results released earlier in 2019 suggest that SGLT2 inhibitors could be a viable treatment solution for patients with diabetes and evidence of kidney damage.…
SGLT2 inhibitor lowers risk of kidney failure in type 2 diabetes Patients with type 2 diabetes mellitus and chronic kidney disease have a lower risk of kidney failure and cardiovascular events if they are treated with canagliflozin, research has confirmed.…
Increased intensity plus adherence maximises statin benefits High adherence to intensive lipid-lowering therapy provides the greatest risk reduction for cardiovascular events, a study in JAMA Network Open has shown.…
Lack of evidence to support statin use in non-cardiovascular conditions There is a lack of ‘convincing’ evidence that statins improve outcomes in non-cardiovascular conditions, such as diabetes, a review has shown.…
Diagnosis and management of anaemia in adults with chronic kidney disease An overview of the treatments for anaemia in chronic kidney disease and the tests needed to prescribe and assess their effectiveness.…
Uncertainty over anticoagulation risks and benefits in CKD patients with AF The risk of both stroke and haemorrhage increases as chronic kidney disease progresses, which can complicate the decision on whether to begin anticoagulation in those with concomitant atrial fibrillation.…